How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Amersham Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
94 clearance records and 0 recall records in the covered releases, across 1 source company names and 40 product codes. Dated history runs from Jul 26, 1976 to Feb 18, 1992.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| AMERLEX-M SPECIFIC ESTRIOL UNCONJUGATEDK844408 · CGI | Amersham Corp. | 510(k) | Dec 11, 1984FDA decision date |
| AMERLEX-M FREE T-3 RIAK842949 · CDP | Amersham Corp. | 510(k) | Sep 5, 1984FDA decision date |
| AMERLEX-M TSH RIAK842948 · JLW | Amersham Corp. | 510(k) | Sep 4, 1984FDA decision date |
| AMERLEX-M FREE T-4 RADIOIMMUNOASSAY KITK842482 · CEC | Amersham Corp. | 510(k) | Aug 10, 1984FDA decision date |
| AMERLEX HUMAN PLACENTAL LACTOGENK840588 · JMF | Amersham Corp. | 510(k) | Apr 4, 1984FDA decision date |
| AMERLEX FREE T-3 RIA KITK830980 · CDP | Amersham Corp. | 510(k) | May 25, 1983FDA decision date |
| AMERLEX B-LCG RIA KITK821031 · JHI | Amersham Corp. | 510(k) | May 3, 1982FDA decision date |
| AMERLEX ESH KITK820754 · CGJ | Amersham Corp. | 510(k) | Apr 15, 1982FDA decision date |
| AMERLEX LH RIA KIT (CODE IM2081)K820753 · CEP | Amersham Corp. | 510(k) | Apr 9, 1982FDA decision date |
| VITAMIN B12/FOLATE DUAL RADIOASSAY KITSK812979 · CGN | Amersham Corp. | 510(k) | Nov 24, 1981FDA decision date |
| GOLD(AU 195) SPOT MARKER SOURCESK812235 · IXD | Amersham Corp. | 510(k) | Sep 9, 1981FDA decision date |
| GOLD(AU 195) GAMMA CAMERA CHECK(FLOOD)K812236 · IYO | Amersham Corp. | 510(k) | Sep 9, 1981FDA decision date |
| AMERLEX TSH RIA KITK812136 · JLW | Amersham Corp. | 510(k) | Aug 13, 1981FDA decision date |
| FERRITIN RIA KITK811804 · DBF | Amersham Corp. | 510(k) | Jul 10, 1981FDA decision date |
| PROSTATIC ACID PHOSPHATASE (PAP) RDA KITK811169 · JFH | Amersham Corp. | 510(k) | May 15, 1981FDA decision date |
| AMERLEX ESTRIOL RIA KITK810667 · CGI | Amersham Corp. | 510(k) | Mar 31, 1981FDA decision date |
| CODE IM 2050 AMERLEX FREE T4 RIA KITK810231 · CEC | Amersham Corp. | 510(k) | Feb 10, 1981FDA decision date |
| DIGOXIN & PHENYTOIN CONTROL SERAK803097 · DIF | Amersham Corp. | 510(k) | Dec 22, 1980FDA decision date |
| GLYCOSYLATED HEMOGLOBIN KITK801561 · LCP | Amersham Corp. | 510(k) | Aug 12, 1980FDA decision date |
| AMERLEX DIGOXIN RIA KITK801413 · LCS | Amersham Corp. | 510(k) | Jul 8, 1980FDA decision date |
| DOSE CALIBRATION REF. SOURCES; BARIUM-13K800867 | Amersham Corp. | 510(k) | May 28, 1980FDA decision date |
| FERRITIN CONTROLS CODE QAS.104K800657 · DBF | Amersham Corp. | 510(k) | Apr 16, 1980FDA decision date |
| AMERLEX CORTISOL RIA KITK800700 · CGR | Amersham Corp. | 510(k) | Apr 16, 1980FDA decision date |
| CODE QAS.105 PROLACTIN CONTROL SERAK800708 · JJX | Amersham Corp. | 510(k) | Apr 16, 1980FDA decision date |
| PROLACTIN RIA KITK800740 · CFT | Amersham Corp. | 510(k) | Apr 16, 1980FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.